A long-standing bureaucratic obstacle to privately-funded medical marijuana research has just been removed, effective immediately. The Department of Health and Human Services determined that the PHS review process is...
Many are screaming “hypocrisy,” and with good reason. How can the U.S. government continue to classify cannabis as a Schedule I drug while simultaneously admitting, at last,...
In a move which may have been made in response to federal pressure to expand options for US researchers trying to study the effects of herbal cannabis...
Scientists who study medical marijuana will soon have access to a wider variety of strains. The National Institute of Drug Abuse (NIDA) — the federal “dealer” that...
